Abstract:Abstract Rationale Glioma progression is driven by the induction of vascular alterations but how the tumor genotype influence these changes is still a pending issue. We propose to study the underlying mechanisms by which the genetic changes in isocitrate dehydrogenase 1/2 ( IDH1/2 ) and epidermal growth factor receptor ( EGFR ) genes establish the different vascular profiles of gliomas. Methods We stratified gliomas based on the genetic status of IDH1/2 and EGFR genes. For that we used in silico data and a cohort of 93 glioma patients, where we analyzed the expression of several transcripts and proteins. For the in vitro and in vivo studies, we used a battery of primary glioblastoma cells derived from patients, as well as novel murine glioma cell lines expressing wild-type or mutant EGFR. In these models, the effect of the small molecule ibrutinib or the downregulation of CD248 and SOX9 was evaluated to establish a molecular mechanism. Results We show that IDH1/2 mutations associate with a normalized vasculature. By contrast, EGFR mutations stimulate the plasticity of glioma cells and their capacity to function as pericytes in a bone-marrow and X-linked (BMX)/SOX9 dependent manner. The presence of tumor-derived pericytes stabilize the profuse vasculature and confers a growth advantage to these tumors, although they render them sensitive to pericyte-targeted molecules. Wild-type/amplified EGFR gliomas are enriched in blood vessels too, but they show a highly disrupted blood-brain-barrier due to a decreased BMX/SOX9 activation and pericyte coverage. This leads to poor nutrient supply, necrosis and hypoxia. Conclusions The function of tumor-derived pericytes delimitates two distinct and aggressive vascular phenotypes in IDH1/2 wild-type gliomas. Our results lay the foundations for a vascular dependent stratification of gliomas and suggest different therapeutic vulnerabilities depending on the genetic status of EGFR . Graphical Abstract. Schematic view of IDH and EGFR function in the regulation of glioma microenvironment. Mutant IDH gliomas express low levels of angiogenic molecules and have a vasculature reminiscent of normal tissue. EGFR mutations drive glioma growth by promoting tumor-to-pericyte transdifferentiation and vascular stabilization in a BMX-SOX9 dependent way. Leaky vessels with hypoxia and necrosis characterize tumors overexpressing the wild-type isoform of the receptor. These phenotypes determine the response to therapy of the different IDH wild-type gliomas.

Low- and high-grade glioma-associated vascular cells differentially regulate tumor growth

Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas

IDH-mutation Status is Associated with Distinct Vascular Gene Expression Signatures in Lower Grade Gliomas.

Transcriptional Profiling of Human Glioblastoma Vessels Indicates a Key Role of VEGF‐A and TGFβ2 in Vascular Abnormalization

A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment

The genetic status of IDH1/2 and EGFR dictates the vascular landscape and the progression of gliomas

Abstract 1024: Mural Cell Transdifferentiation of Glioblastoma Stem-Like Cells Drives Vasculogenic Mimicry in Glioblastoma Development

Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying EGFR

Quantitative analysis for the differences in vasculogenic activity and sensitivity to angiogenic stimulants between human glioma cells and normal endothelial cells

Transdifferentiation Of Glioblastoma Stem-Like Cells Into Mural Cells Drives Vasculogenic Mimicry In Glioblastomas

Anti-Vascular Endothelial Growth Factor Therapy Abolishes Glioma-Associated Endothelial Cell-Induced Tumor Invasion

Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade

Glioma Stem/Progenitor Cells Contribute to Neovascularization Via Transdifferentiation

Glioblastoma Stem Cell-Derived Pericytes and Tumor Angiogenesis

Microvascular Characteristics of Lower-Grade Diffuse Gliomas: Investigating Vessel Size Imaging for Differentiating Grades and Subtypes.

Elevated Expression Of The C-Type Lectin Cd93 In The Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function And Reduce Host Survival

Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles

Angi-03. Glioma Stem Cells Induce Vasectasia – A Non-Angiogenic Brain Tumour Neovascularization Process Driven By Intercellular Egfr Transfer Through Extracellular Vesicles

Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth

Glioma-Derived Mirna-Containing Extracellular Vesicles Induce Angiogenesis by Reprogramming Brain Endothelial Cells.

Association Between Glioblastoma Cell‐derived Vessels and Poor Prognosis of the Patients